胰腺外分泌功能不全诊治规范(2018,广州)

中国医师协会胰腺病专业委员会慢性胰腺炎专委会

doi:10.3969/j.issn.1001-5256.2019.02.010

胰腺外分泌功能不全诊治规范(2018,广州)

DOI: 10.3969/j.issn.1001-5256.2019.02.010

中国医师协会胰腺病专业委员会慢性胰腺炎专委会

详细信息

中图分类号: R576
计量
- 文章访问数: 647
- HTML全文浏览量: 28
- PDF下载量: 366
- 被引次数: 0
出版历程
- 出版日期: 2019-02-20

Standards for the diagnosis and treatment of pancreatic exocrine insufficiency (2018, Guangzhou)

Special Committee on Chronic Pancreatitis, Pancreatic Disease Specialized Committee, Chinese Medical Doctor Association

摘要

摘要:
<正>胰腺外分泌功能不全(pancreatic exocrine insufficiency,PEI)是指由于各种原因引起的胰酶分泌不足或胰酶分泌不同步,而导致患者出现营养消化吸收不良等症状[1]。中国医师协会胰腺病专业委员会慢性胰腺炎专委会牵头内科、外科、病理、影像等多学科专家,参照最新循证医学证据和多部国际权威指南,对2012年版《中国胰腺外分泌功能不全诊治规范(草案)》
- 胰腺外分泌功能不全 /
- 胰腺炎 /
- 囊性纤维化 /
- 胰腺功能试验 /
- 诊疗准则
- exocrine pancreatic insufficiency /
- pancreatitis /
- cystic fibrosis /
- pancreatic function tests /
- practice guideline

HTML全文

参考文献(41)

[1] Editorial Board of Chinese Journal of Pancreatology.Chinese standard for the diagnosis and treatment of exocrine pancreatic insufficiency (draft) [J].Chin J Pancreatol, 2013, 13 (1) :45-48. (in Chinese) 《中华胰腺病杂志》编委会.中国胰腺外分泌功能不全诊治规范 (草案) [J].中华胰腺病杂志, 2013, 13 (1) :45-48.

[2]LVY P, BARTHET M, MOLLARD BR, et al.Estimation of the prevalence and incidence of chronic pancreatitis and its complications[J].Gastroenterol Clin Biol, 2006, 30 (6-7) :838-844.

[3]MARRA-LOPEZ VALENCIANO C, BOLADO CONCEJO F, MARIN SERRANO E, et al.Prevalence of exocrine pancreatic insufficiency in patients with chronic pancreatitis without follow-up.PANCR-EVOL Study[J].Gastroenterol Hepatol, 2018, 41 (2) :77-86.

[4]HO TW, WU JM, KUO TC, et al.Change of both endocrine and exocrine insufficiencies after acute pancreatitis in non-diabetic patients:A nationwide population-based study[J].Medicine (Baltimore) , 2015, 94 (27) :e1123.

[5]BOREHAM B, AMMORI BJ.A prospective evaluation of pancreatic exocrine function in patients with acute pancreatitis:Correlation with extent of necrosis and pancreatic endocrine insufficiency[J].Pancreatology, 2003, 3 (4) :303-308.

[6]HOLLEMANS RA, HALLENSLEBEN NDL, MAGER DJ, et al.Pancreatic exocrine insufficiency following acute pancreatitis:Systematic review and study level meta-analysis[J].Pancreatology, 2018, 18 (3) :253-262.

[7]XU Y, WU D, ZENG Y, et al.Pancreatic exocrine function and morphology following an episode of acute pancreatitis[J].Pancreas, 2012, 41 (6) :922-927.

[8]ANTONINI F, CRIPPA S, FALCONI M, et al.Pancreatic enzyme replacement therapy after gastric resection:An update[J].Dig Liver Dis, 2018, 50 (1) :1-5.

[9]PEZZILLI R, ANDRIULLI A, BASSI C, et al.Exocrine pancreatic insufficiency in adults:A shared position statement of the Italian Association for the Study of the Pancreas[J].World JGastroenterol, 2013, 19 (44) :7930-7946.

[10]FRIESS H, BOHM J, MULLER MW, et al.Maldigestion after total gastrectomy is associated with pancreatic insufficiency[J].Am J Gastroenterol, 1996, 91 (2) :341-347.

[11]SIKKENS EC, CAHEN DL, de WIT J, et al.A prospective assessment of the natural course of the exocrine pancreatic function in patients with a pancreatic head tumor[J].J Clin Gastroenterol, 2014, 48 (5) :e43-e6.

[12]SABATER L, AUSANIA F, BAKKER OJ, et al.Evidencebased guidelines for the management of exocrine pancreatic insufficiency after pancreatic surgery[J].Ann Surg, 2016, 264 (6) :949-958.

[13]MAIGNAN A, OUAISSI M, TURRINI O, et al.Risk factors of exocrine and endocrine pancreatic insufficiency after pancreatic resection:A multi-center prospective study[J].J Visc Surg, 2018, 155 (3) :173-181.

[14]OTHMAN MO, HARB D, BARKIN JA.Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician[J].Int J Clin Pract, 2018, 72 (2) :e13066.

[15]ZSORI G, ILLES D, TERZIN V, et al.Exocrine pancreatic insufficiency in type 1 and type 2 diabetes mellitus:Do we need to treat it?A systematic review[J].Pancreatology, 2018.[Epub ahead of print]

[16]DIMAGNO EP, GO VL, SUMMERSKILL WH.Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency[J].N Engl J Med, 1973, 288 (16) :813-815.

[17]LI BR, PAN J, DU TT, et al.Risk factors for steatorrhea in chronic pancreatitis:A cohort of 2, 153 patients[J].Sci Rep, 2016, 6:21381.

[18]DOMINGUEZ-MUNOZ JE, IGLESIAS-GARCIA J.Oral pancreatic enzyme substitution therapy in chronic pancreatitis:Is clinical response an appropriate marker for evaluation of therapeutic efficacy?[J].JOP, 2010, 11 (2) :158-162.

[19]DUGGAN SN, SMYTH ND, O'SULLIVAN M, et al.The prevalence of malnutrition and fat-soluble vitamin deficiencies in chronic pancreatitis[J].Nutr Clin Pract, 2014, 29 (3) :348-354.

[20]de la IGLESIA-GARCIA D, VALLEJO-SENRA N, IGLESIAS-GARCIA J, et al.Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis[J].J Clin Gastroenterol, 2018, 52 (8) :e63-e72.

[21]DOMNGUEZ MUOZ JE.Diagnosis of chronic pancreatitis:Functional testing[J].Best Pract Res Clin Gastroenterol, 2010, 24 (3) :233-241.

[22]STEVENS T, CONWELL DL, ZUCCARO G JR, et al.A prospective crossover study comparing secretin-stimulated endoscopic and Dreiling tube pancreatic function testing in patients evaluated for chronic pancreatitis[J].Gastrointest Endosc, 2008, 67 (3) :458-466.

[23]DOMINGUEZ-MUNOZ JE, NIETO L, VILARINO M, et al.Development and diagnostic accuracy of a breath test for pancreatic exocrine insufficiency in chronic pancreatitis[J].Pancreas, 2016, 45 (2) :241-247.

[24]LANKISCH PG.Secretion and absorption (methods and functions) [J].Best Pract Res Clin Gastroenterol, 2009, 23 (3) :325-335.

[25]VANGA RR, TANSEL A, SIDIQ S, et al.Diagnostic performance of measurement of fecal elastase-1 in detection of exocrine pancreatic insufficiency-systematic review and metaanalysis[J].Clin Gastroenterol Hepatol, 2018, 16 (8) :1220-1228.e4.

[26]SUGAI E, SRUR G, VAZQUEZ H, et al.Steatocrit:A reliable semiquantitative method for detection of steatorrhea[J].J Clin Gastroenterol, 1994, 19 (3) :206-209.

[27]NIKFARJAM M, WILSON JS, SMITH RC, et al.Diagnosis and management of pancreatic exocrine insufficiency[J].Med JAust, 2017, 207 (4) :161-165.

[28]MADZAK A, OLESEN SS, WATHLE GK, et al.Secretin-stimulated magnetic resonance imaging assessment of the benign pancreatic disorders:Systematic review and proposal for a standardized protocol[J].Pancreas, 2016, 45 (8) :1092-1103.

[29]BILGIN M, BALCI NC, MOMTAHEN AJ, et al.MRI and MRCPfindings of the pancreas in patients with diabetes mellitus:Compared analysis with pancreatic exocrine function determined by fecal elastase 1[J].J Clin Gastroenterol, 2009, 43 (2) :165-170.

[30]SIKKENS EC, CAHEN DL, KOCH AD, et al.The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis[J].Pancreatology, 2013, 13 (3) :238-342.

[31]LINDKVIST B, DOMINGUEZ-MUNOZ JE, LUACES-REGUEIRAM, et al.Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis[J].Pancreatology, 2012, 12 (4) :305-310.

[32]GHEORGHE C, SEICEAN A, SAFTOIU A, et al.Romanian guidelines on the diagnosis and treatment of exocrine pancreatic insufficiency[J].J Gastrointestin Liver Dis, 2015, 24 (1) :117-123.

[33]LOHR JM, DOMINGUEZ-MUNOZ E, ROSENDAHL J, et al.United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (Ha Pan EU) [J].United European Gastroenterol J, 2017, 5 (2) :153-199.

[34]Working Party of the Australasian Pancreatic C, SMITH RC, SMITH SF, et al.Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency[J].Pancreatology, 2016, 16 (2) :164-180.

[35]LUACES-REGUEIRA M, IGLESIAS-GARCIA J, LINDKVISTB, et al.Smoking as a risk factor for complications in chronic pancreatitis[J].Pancreas, 2014, 43 (2) :275-280.

[36]de la IGLESIA-GARCIA D, HUANG W, SZATMARY P, et al.Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis:Systematic review and meta-analysis[J].Gut, 2017, 66 (8) :1354-1355.

[37]D'HAESE JG, CEYHAN GO, DEMIR IE, et al.Pancreatic enzyme replacement therapy in patients with exocrine pancreatic insufficiency due to chronic pancreatitis:A 1-year disease management study on symptom control and quality of life[J].Pancreas, 2014, 43 (6) :834-841.

[38]RAMESH H, REDDY N, BHATIA S, et al.A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis[J].Pancreatology, 2013, 13 (2) :133-139.

[39]CATARCI M, BERLANDA M, GRASSI GB, et al.Pancreatic enzyme supplementation after gastrectomy for gastric cancer:A randomized controlled trial[J].Gastric Cancer, 2018, 21 (3) :542-551.

[40]DOMINGUEZ-MUNOZ JE, IGLESIAS-GARCIA J, IGLESIAS-REY M, et al.Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency:A randomized, three-way crossover study[J].Aliment Pharmacol Ther, 2005, 21 (8) :993-1000.

[41]DOMINGUEZ-MUNOZ JE, IGLESIAS-GARCIA J, VILARINO-INSUA M, et al.13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis[J].Clin Gastroenterol Hepatol, 2007, 5 (4) :484-488.

施引文献

资源附件(0)

访问统计